Document Type
Article
Publication Date
3-6-2010
Abstract
In response to increasing public distrust and congressional concerns regarding pharmaceutical company influence on medical research and education, professional organizations have taken steps to phase out or regulate industry-sponsored educational support. A related problem is industry funding of philanthropic organizations, such as patient advocacy groups. Thus, when the office of Sen Charles Grassley (R-Iowa) recently reported that the National Alliance for the Mentally Ill received substantial pharmaceutical funding, there was concern among the membership’s psychiatric patients and their families.
Recommended Citation
Cosgrove, Lisa and Harold J. Bursztajn, "Pharmaceutical Philanthropic Shell Games." Psychiatric Times (March 6, 2010).
Publisher
UBM Medica LLC
Included in
Bioethics and Medical Ethics Commons, Mental Disorders Commons, Pharmacy Administration, Policy and Regulation Commons
Comments
This article appears in the Psychiatric Times, published by UBM Medica LLC: http://www.psychiatrictimes.com/articles/pharmaceutical-philanthropic-shell-games.